Search Results for keywords:"synthetic opioid supply chain"

The Department of Homeland Security has updated the rules regarding additional duties on products from China, including Hong Kong, due to changes in an Executive Order. These changes raise the tariffs from 10% to 20% on certain items, effective March 4, 2025. The order is part of a response to what the U.S. views as China's inadequate control over synthetic opioid supply chains. Some exceptions apply, such as items qualifying for de minimis exemptions, but these could change if the government determines that enough systems are in place to manage tariff revenues.

The President issued Executive Order 14200, which amends a previous order regarding tariffs on goods related to the synthetic opioid supply chain from China. The amendment allows certain goods that are typically duty-free to remain so, unless the Secretary of Commerce tells the President that the systems for collecting tariffs are working well. Additionally, the order clarifies that it doesn't change the authority of any government department or create new legal rights for anyone against the government.

The U.S. Department of Homeland Security, through U.S. Customs and Border Protection, has issued an amended notice imposing additional duties on products imported from China, following an executive order by the President aimed at addressing the synthetic opioid supply chain. The notice modifies the Harmonized Tariff Schedule of the United States to include new duty rates and clarifies that certain goods, such as those eligible for the de minimis exemption, may still qualify for duty-free treatment until new systems to process tariffs are in place. The additional duties are effective for products entered from February 5, 2025, and specific provisions are outlined for goods in transit before that date. Importation exceptions include certain personal items and goods eligible for temporary duty reductions.

The Department of Homeland Security, along with U.S. Customs and Border Protection, has issued a notice to update tariffs on goods imported from China following a presidential order issued on February 1, 2025. This measure is part of an effort to combat the synthetic opioid supply chain in China, and it imposes an additional 10% duty on these imports. Certain exemptions apply, but most products from China, including Hong Kong, will be subject to this new duty if consumed or withdrawn after February 4, 2025. The document stresses that these new fees will apply alongside existing tariffs and precautions are in place to prevent duty-free treatment for these goods.